Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Richard Klausner, Dietrich Stephan

Premium

Richard Klausner has been named senior vice president and chief medical officer at Illumina.

Klausner joins Illumina from the Column Group, a venture capital firm. He previously served as executive director for global health at the Bill and Melinda Gates Foundation and as director of the US National Cancer Institute from 1995 to 2001.

Klausner holds an MD from Duke Medical School.


Dietrich Stephan has been named chair of the department of human genetics at the University of Pittsburgh Graduate School of Public Health and will also serve as the associate director of the Institute for Personalized Medicine, a collaborative initiative between the University of Pittsburgh Schools of the Health Sciences and UPMC.

Stephan was most recently founder, president, and CEO of Silicon Valley Biosystems. He also co-founded personal genetics firm Navigenics. Prior to that, Stephan held a number of roles at the Translational Genomics Research Institute, including director of neurogenomics. He was also head of the NIH Neuroscience Microarray Consortium for seven years.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.